Licochalcone A Ameliorates Metabolic-Associated Fatty Liver Disease by AMPK Signaling Pathway Activation through O-GlcNAcylation Regulation and Remodeling of Gut Microbiota and Associated Metabolites
Journal of Agricultural and Food Chemistry · 04.11.2026 · 74 (43) · 33853-33871
DOI: 10.1021/acs.jafc.6c04497 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Agricultural and Food Chemistry, online erschienen am 22.10.2026. Verfasst von Shuai Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: College of Animal Science and Technology, Henan University of Science and Technology, Luoyang471023, China. Hauptthemen laut MEDLINE: Chalcones, AMP-Activated Protein Kinases, Gastrointestinal Microbiome. Die Arbeit nennt 40 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Liaoning Province, National Key Research and Development Program of China.
Abstract (Originalsprache)
Metabolic-associated fatty liver disease (MAFLD) is a major global chronic liver disorder with serious health risks. Licorice-derived licochalcone A (LA) exhibits protective activities against multiple chronic conditions. Herein, we investigated the preventive and therapeutic effects of LA on MAFLD. LA alleviated hepatic lipid accumulation, oxidative stress, and inflammation in MAFLD mice, and activated the AMPK pathway via O-GlcNAcylation. Furthermore, LA treatment restored intestinal barrier function and reshaped gut microbiota, elevating the relative abundance of Muribaculaceae and Parasutterella. Gut microbiota depletion and FMT assays demonstrated that gut microbiota are indispensable for LA-mediated MAFLD amelioration and hepatic O-GlcNAcylation regulation. Dodecanedioic acid (DA), a lipid-metabolism-related metabolite, improved MAFLD through AMPK activation. In vitro assays confirmed that LA and DA inhibited AMPK O-GlcNAcylation to boost AMPK phosphorylation and reduce cellular lipid deposition. These results offer new mechanistic perspectives regarding the hepatoprotective properties of LA and confirm its therapeutic potential to treat MAFLD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Animal Science and Technology, Henan University of Science and Technology, Luoyang471023, China.
- School of Medical Technology and Engineering, Henan University of Science and Technology, Luoyang471023, China.
ORCID-Profile: Shuai Wang
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Liaoning Province
- National Key Research and Development Program of China
Zitieren
APA
Wang, S., Guo, S., Wang, X., Wang, H., Wang, J., Ma, Y., Zhao, S., & Zhang, C. (2026). Licochalcone A Ameliorates Metabolic-Associated Fatty Liver Disease by AMPK Signaling Pathway Activation through O-GlcNAcylation Regulation and Remodeling of Gut Microbiota and Associated Metabolites. Journal of Agricultural and Food Chemistry, 74(43), 33853-33871. https://doi.org/10.1021/acs.jafc.6c04497
Vancouver
Wang S, Guo S, Wang X, Wang H, Wang J, Ma Y, et al. Licochalcone A Ameliorates Metabolic-Associated Fatty Liver Disease by AMPK Signaling Pathway Activation through O-GlcNAcylation Regulation and Remodeling of Gut Microbiota and Associated Metabolites. Journal of Agricultural and Food Chemistry. 2026;74(43):33853-33871. doi:10.1021/acs.jafc.6c04497
BibTeX
@article{Wang2026,
author = {Wang, Shuai and Guo, Shuai and Wang, Xinjuan and Wang, Hongwei and Wang, Jicang and Ma, Yanbo and Zhao, Shanshan and Zhang, Cai},
title = {Licochalcone A Ameliorates Metabolic-Associated Fatty Liver Disease by AMPK Signaling Pathway Activation through O-GlcNAcylation Regulation and Remodeling of Gut Microbiota and Associated Metabolites},
journal = {Journal of Agricultural and Food Chemistry},
year = {2026},
volume = {74},
number = {43},
pages = {33853--33871},
doi = {10.1021/acs.jafc.6c04497}
}
EUVIMED